-
1361
-
1362“…Entry of hepatitis C virus (HCV) into hepatocytes is a multi-step process that involves a number of different host cell factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1363“…We report a first case of lichen planus pigmentosus with bilateral linear distribution associated with hepatitis C virus infection. The lesion was improved after sun avoidance and treatment of hepatitis C virus infection with a combination of interferon and ribavirin. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1364por Jadoon, Nauman A, Shahzad, Mohammad A, Yaqoob, Rehan, Hussain, Mansoor, Ali, Naseema“…BACKGROUND: There is a growing body of literature on the relationship of Hepatitis C virus infection (HCV) and type 2 diabetes mellitus (T2DM). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1365
-
1366por Surjadi, Miranda, Torruellas, Cara, Ayala, Claudia, Yee, Hal F., Khalili, Mandana“…BACKGROUND: Hepatitis C (HCV) knowledge is limited in injection drug users (IDU). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1367“…Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are the most prevalent deadly chronic viral diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1368por Inamullah, Idrees, Muhammad, Ahmed, Habib, Sajid-ul-Ghafoor, Ali, Muhammad, Ali, Liaqat, Ahmed, Aziz“…Hepatitis C virus (HCV) is the leading cause of chronic hepatitis worldwide and its subtypes/genotypes are clinically important for clinical management and vaccine development. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1369“…The current standard of care for hepatitis C virus (HCV) infection – combination therapy with pegylated interferon and ribavirin – elicits sustained responses in only ∼50% of the patients treated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1370“…INTRODUCTION: Response to current therapy of hepatitis C virus (HCV) is suboptimal. Direct-acting antiviral therapies (DAA) are expected to improve treatment outcomes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1371por Ré, Viviana E., Culasso, Andrés C. A., Mengarelli, Silvia, Farías, Adrián A., Fay, Fabián, Pisano, María B., Elbarcha, Osvaldo, Contigiani, Marta S., Campos, Rodolfo H.“…The Hepatitis C Virus Genotype 2 subtype 2c (HCV-2c) is detected as a low prevalence subtype in many countries, except in Southern Europe and Western Africa. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1372“…Interferon-α, currently used for the treatment of hepatitis C, is associated with a substantially elevated risk of depression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1373“…There is a notable dearth of data about Hepatitis B Virus (HBV) and Hepatitis C Virus(HCV) prevalence in Afghanistan. Awareness program and research capacity in the field of hepatitis are very limited in Afghanistan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1374“…Host cyclophilin (cyp) inhibitors, such as NIM811, efficiently inhibit replication of hepatitis C virus (HCV) and have shown significant promise in recent clinical trials for the treatment of chronic HCV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1375por Alavian, Seyed-Moayed, Miri, Seyyed Mohammad, Tabatabaei, Seyed-Vahid, Keshvari, Maryam, Behnava, Bita, Elizee, Pegah Karimi, Mahboobi, Nastaran, Lankarani, Kamran Bagheri“…BACKGROUND/AIMS: The distribution of blood lipids, glucose and their determinants in thalassemic patients with chronic hepatitis C virus (HCV) infection has rarely been investigated. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1376por Thomas, David L., Thio, Chloe L., Martin, Maureen P., Qi, Ying, Ge, Dongliang, O’hUigin, Colm, Kidd, Judith, Kidd, Kenneth, Khakoo, Salim I., Alexander, Graeme, Goedert, James J., Kirk, Gregory D., Donfield, Sharyne M., Rosen, Hugo R., Tobler, Leslie H., Busch, Michael P., McHutchison, John G., Goldstein, David B., Carrington, Mary“…Hepatitis C virus (HCV) infection is the most common blood borne infection in the U.S. with estimates of 4 million HCV-infected individuals in the U.S. and 170 million worldwide(1). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1377por Danilovic, Debora Lucia Seguro, Mendes-Correa, Maria Cassia, Chammas, Maria Cristina, Zambrini, Heverton, Marui, Suemi“…OBJECTIVE: To characterize thyroid disturbances induced by interferon-alpha and ribavirin therapy in patients with chronic hepatitis C. INTRODUCTION: Interferon-alpha is used to treat chronic hepatitis C infections. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1378“…Hepatitis C virus (HCV) core protein is directed to the surface of lipid droplets (LD), a step that is essential for infectious virus production. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1379por Yang, Darong, Liu, Nianli, Zuo, Chaohui, Lei, Shoahua, Wu, Xinjiao, Zhou, Fei, Liu, Chen, Zhu, Haizhen“…BACKGROUND AND AIM: The interaction between hepatitis C virus (HCV) and innate antiviral defense systems in primary human hepatocytes is not well understood. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1380“…Hepatitis C virus (HCV) infection is one of the most common indications for liver transplantation worldwide. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto